Development of tolerogenic plasmid vectors for gene therapy of Duchenne muscular dystrophy (DMD)
This project focused on the development of an effective gene replacement therapy for the Duchenne muscular dystrophy (DMD) in its mouse models [(X-linked muscular dystrophy, mdx) and mdx-βgeo mice]. Earlier studies on the DMD replacement therapy (usually using mini-dystrophin) were largely not succe...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University of Portsmouth
2017
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.765653 |